
|

| |
Track the *RXDIA Index |
 |
|
 | Diabetes Stocks (*RXDIA) |
| |
Diabetes Ideas |
|
|
|
Diabetes Performance |
|
|
|
Diabetes Community |
|
| |
|
Index Description: These medical firms have significant exposure to treatments and therapies for diabetes
|
|
|
|
|
Today:
1-month:
All-time:
|
+2.4%
+12.5%
+1.6%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+1.4%
+5.1%
-19.3%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$11.0B
0.0
0.1%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ARRY |
$5.89 |
+0.20 |
+3.5% |
912,437 |
70% |
$687.2M |
- |
96% |
-10% |
No Alerts/News
|
|
|
| BIOD |
$3.28 |
-0.02 |
-0.6% |
277,832 |
314% |
$46.5M |
- |
54% |
-14% |
No Alerts/News
|
|
|
| DEPO |
$5.48 |
+0.08 |
+1.5% |
674,139 |
137% |
$309.6M |
- |
15% |
-23% |
No Alerts/News
|
|
|
| DXCM |
$21.18 |
+1.73 |
+8.9% |
1,331,180 |
255% |
$1.4B |
- |
106% |
5% |
No Alerts/News
|
|
|
| GNBT |
$0.03 |
0.00 |
+1.9% |
697,179 |
64% |
$19.4M |
- |
34% |
-76% |
No Alerts/News
|
|
|
| MNKD |
$5.19 |
+0.03 |
+0.6% |
10,209,096 |
195% |
$1.5B |
- |
231% |
0% |
1 Alert (1 News) - View
|
|
|
| NVO |
$171.99 |
0.00 |
0.0% |
219,767 |
95% |
$93.6B |
1.3% |
33% |
-12% |
No Alerts/News
|
|
|
| PODD |
$29.66 |
+0.42 |
+1.4% |
280,575 |
55% |
$1.5B |
- |
71% |
-1% |
No Alerts/News
|
|
|
| SPEX |
$7.16 |
-0.30 |
-4.1% |
1,710 |
57% |
$5.8M |
- |
30% |
-58% |
No Alerts/News
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
'Love Hormone' Promises Safer Births After Pfizer Flop PFE MNKD NKTR
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 19, 06:03PM from (www.bloomberg.com) A hormone treatment based on technology used in Pfizer Inc. (PFE)’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
Flag
Post a comment
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials ARRY
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 16, 02:18AM from (www.bloomberg.com) AstraZeneca Plc (AZN) will move three experimental cancer treatments into late-stage development as generic competition for its best-selling drugs intensifies.
Flag
Post a comment
MannKind Corporation Reports 2013 First Quarter Financial Results MNKD
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 09, 04:00PM from (www.businesswire.com) MannKind Corporation (Nasdaq: MNKD) today reported financial results for the first quarter ended March 31, 2013. For the
Flag
Post a comment
Biodel Reports Second Quarter Fiscal Year 2013 Financial Results BIOD
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 07:43AM from (globenewswire.com) DANBURY, Conn., May 8, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported financial results for the second
Flag
Post a comment
Insulet Corporation to Report First Quarter 2013 Financial Results on May 6, 2013 PODD
Linked by marketwire ( track newsfeed | ignore newsfeed ) - April 23, 04:48PM from (www2.marketwire.com) Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management
Flag
Post a comment
Merck’s $4 Billion Diabetes Drug in Trouble? BMY LLY MRK NVO AZN
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - April 18, 11:55AM from (ycharts.com) For the past two months, there has been rising controversy over the extent to which certain diabetes drugs called GLP-1 inhibitors
Flag
Post a comment
Mid-Day Market Update: Precious Metals Take a Beating as Markets Recover JPM WFC RAD MNKD SBGI NG AUY ASH
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - April 12, 01:34PM from (www.benzinga.com) Midway through trading Friday, the Dow traded down 0.04 percent to 14,858.98 while the NASDAQ fell 0.34 percent to 3,289.44.
Flag
Post a comment
Mid-Day Market Update: ADTRAN Soars as Titan Takes a Hit HMA MNKD JDSU ADTN FSLR TITN
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - April 10, 12:53PM from (www.benzinga.com) Midway through trading Wednesday, the Dow traded up 0.97 percent to 14,815.98 while the NASDAQ rose 1.79 percent to 3,295.44.
Flag
Post a comment
Market Close: Big Winners & Losers for April 2, 2013 SPEX TCCO CLNT NAT BOSC IGOI BGCP NDAQ OPTR CHCI
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - April 02, 04:27PM from (247wallst.com) Here are today’s five biggest gaining stocks at closing: BGC Partners Inc. (NASDAQ: BGCP) is up 48.3% at $5.71. B.O.S.
Flag
Post a comment
|
|
|